Description
Abstract Background The course of disease for patients with idiopathic pulmonary fibrosis (IPF) is highly heterogeneous. Prognostic models rely on demographic and clinical characteristics and are not reproducible. Integrating data from genomic analyses ...
| Date made available | 2015 |
|---|---|
| Publisher | figshare |
Cite this
- DataSetCite